Tetsuya Matoba and Japan Free People Check 

( I'm Tetsuya Matoba)
(1 - 11 from 12
)

AFIRE: Rivaroxaban monotherapy outperforms dual therapy in AF ...www.healio.com › news › cardiac-vascular-intervention › afire-rivaroxaba...

www.healio.com
Nov 10, · For the present substudy, Tetsuya Matoba, MD, PhD, of Kyushu University in Fukuoka, Japan, and colleagues evaluated rivaroxaban monotherapy ...
+1